UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000038322
Receipt No. R000043679
Scientific Title Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study
Date of disclosure of the study information 2019/10/18
Last modified on 2019/10/17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study
Acronym Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study
Scientific Title Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study
Scientific Title:Acronym Effect of continuing anticoagulants and antiplatelet drugs on perioperative total blood loss in total hip replacement: a prospective observational study
Region
Japan

Condition
Condition Osteoarthritis of the hip, rheumatoid arthritis, avascular necrosis of the femoral head
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigated the impact of continuing anticoagulants or antiplatelet drugs on perioperative blood loss in total hip arthroplasty.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The volume of perioperative blood loss measured using the calculated blood volume and change in hemoglobin from preoperative to postoperative day 4.
Key secondary outcomes Complication

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients undergoing total hip arthroplasty
Key exclusion criteria Patients scheduled for revision total hip arthroplasty.
Patients scheduled for total hip arthroplasty with shortening subtrochanteric osteotomy.
Target sample size 500

Research contact person
Name of lead principal investigator
1st name Kenji
Middle name
Last name Kurosaka
Organization Hokusuikai Kinen Hospital
Division name Orthopaedic surgery
Zip code 310-0035
Address 3-2-1 Higashihara, Mito, Ibaraki, Japan
TEL 029-303-3003
Email kenjikurosaka@yahoo.co.jp

Public contact
Name of contact person
1st name kenji
Middle name
Last name Kurosaka
Organization Hokusuikai Kinen Hospital
Division name Orthopaedic surgery
Zip code 310-0035
Address 3-2-1 Higashihara, Mito, Ibaraki, Japan
TEL 029-303-3003
Homepage URL
Email kenjikurosaka@yahoo.co.jp

Sponsor
Institute Hokusuikai Kinen Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hokusuikai Kinen Hospital
Address 3-2-1 Higashihara, Mito, Ibaraki, Japan
Tel 029-303-3003
Email kenjikurosaka@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北水会記念病院 茨城県

Other administrative information
Date of disclosure of the study information
2019 Year 10 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 04 Month 01 Day
Date of IRB
2019 Year 10 Month 03 Day
Anticipated trial start date
2019 Year 10 Month 03 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information perioperative total blood loss
Complication

Management information
Registered date
2019 Year 10 Month 17 Day
Last modified on
2019 Year 10 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043679

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.